Because of pathological mechanisms that may be shared by certain comorbidities and AD, such as the accumulation of amyloid-beta (Aβ) and the presence of the APOE ε4 allele, there may be modifications to the clinical progression of AD. This evidence concerns the gene APOE and Alzheimer disease.